Crescent Biopharma (CBIO)

Crescent Biopharma (CBIO) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• CBIO last traded at $13.48, -4.19% on the day.
• Crescent Biopharma: market cap $500.74M, P/E -1.7, next earnings 2026-11-05.
• Over the past year CBIO returned 7.75%; year to date 13.66%.

Updated 2026-11-02 17:51 UTC